Inactive ingredient listing should be required on outer container only, NDMA tells FDA.
This article was originally published in The Tan Sheet
Executive Summary
INACTIVE INGREDIENT PLACEMENT ON OUTER CONTAINER ONLY suggested by the Nonprescription Drug Manufacturers Association in March 31 comments to FDA. The decision to use an OTC product is "ordinarily made at the point of purchase, therefore the listing generally should be visible at that point," NDMA asserts, adding that the space on a product's inner container should be "conserved for other required labeling." The association's comments address the listing of active and inactive ingredients on OTC labels as required by the FDA Modernization Act.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning